News

Filter

Current filters:

MabTheraSimponi Injection

UK’s NICE recommends Merck’s Simponi for RA and Roche’s MabThera for first-line use

23-06-2011

The UK drugs watchdog the National Institute for Health and Clinical Excellence (NICE) has issued final…

Anti-Arthritics/RheumaticsEuropeMabTheraMerck & CoOncologyPharmaceuticalPricingRegulationRocheSimponi Injection

Back to top